Frontlight ResearchEarly access
Trial site
Columbia University Medical Center New York Presbyterian
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Chronic myeloid leukaemia2 trials
- Aortic stenosis1 trial
- Crohn's disease1 trial
- Cytomegalovirus infection1 trial
- Heart failure1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Abbott Medical Devices1 trial
- Columbia University1 trial
- Cytokinetics1 trial
- Eli Lilly and Company1 trial
- and 1 more
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Active, not recruiting
Recruiting
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Recruiting
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Crohn's disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Heart failure1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026